How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

PBMCs or Whole Blood? Strategic Applications in Phase I Studies

calendar_today August 28, 2025 person Celerion domain celerion-hig-capital

Your browser does not support the audio element. ⬇ Download MP3 Studying peripheral blood mononuclear cells (PBMCs) reveals cell-specific biomarkers—like target engagement and receptor occupancy—that improve decision-making in Phase I clinical trials. This makes these assays incredibly powerful tools in early-phase studies and has resulted in a growing trend of incorporating PBMC isolation and flow […] The post PBMCs or Whole Blood?

open_in_new Read original post